计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| R646144-5mg |
5mg |
期货 ![]() |
| |
| R646144-10mg |
10mg |
期货 ![]() |
| |
| R646144-25mg |
25mg |
期货 ![]() |
| |
| R646144-50mg |
50mg |
期货 ![]() |
| |
| R646144-100mg |
100mg |
期货 ![]() |
|
| 别名 | RORγt 反向激动剂 6 |
|---|---|
| 规格或纯度 | ≥98% |
| 英文名称 | RORγt Inverse agonist 6 |
| 生化机理 | RORγt 反向激动剂 6(化合物 43)是一种 RORγt 反向激动剂,用于研究 Th17 驱动的自身免疫性疾病。RORγt 反向激动剂 6(化合物 43)通过 IL-23 刺激抑制体内 IL-17A 基因的表达。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
RORγt Inverse agonist 6 (compound 43) is a RORγt inverse agonist for the study of Th17-driven autoimmune diseases. RORγt Inverse agonist 6 (compound 43) suppresses IL-17A gene expression by IL-23 stimulation in vivo. In Vivo RORγt Inverse agonist 6 (compound 43) suppresses IL-17A gene expression by IL-23 stimulation in a mouse pharmacodynamics model . RORγt Inverse agonist 6 (compound 43) exhibits improved drug exposure (mouse AUC: 1289 ng•h/mL at 1 mg/kg, po) . RORγt Inverse agonist 6 (compound 43, 30 mg/kg, po, b.i.d) inhibits the expression level of IL-17A by 59% compared to the vehicle after the oral administration at the tested dose . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Mice . Dosage: 30 mg/kg. Administration: Orally twice: at 30 min before and 8 h after IL-23 administration. Result: Inhibited the expression level of IL-17A by 59% compared to the vehicle after the oral administration at the tested dose. Form:Solid |
| 纯度 | ≥98% |
| Smiles | O=C([C@H]1CN(C(NC2=CC3=C(N(C(C)C)C(N(CC4CC4)C3=O)=O)C=C2)=O)CCO1)NC5=CC=C(C#N)C(Cl)=C5 |
|---|---|
| 分子量 | 565.02 |
| 溶解性 | DMSO : 50 mg/mL (88.49 mM; Need ultrasonic) |
|---|